Members of Technical Staff 🚨 Emergency Pod 🚨 Chinese Peptides Made the NYT, with Sina Hartung
9 snips
Jan 4, 2026 Sina Hartung, a health-tech founder and former endocrinology clinic operator, joins to unpack her insights on the buzz surrounding unregulated Chinese peptides. The duo dives into the meme's origins in wellness circles and differentiates between peptides, SARMs, and steroids, emphasizing personalized risk assessments. Sina shares her clinical perspective and discusses the implications of weight-loss drugs for different demographics. They also critique DIY wellness culture, revealing safety concerns and cultural trends in health, all while making bold predictions for the future.
AI Snips
Chapters
Transcript
Episode notes
Origin Of The 'Chinese Peptides' Meme
- Jayden credits himself for popularizing the phrase “Chinese peptides” and notes media attribution amplified the meme.
- He frames the trend as real in Bay Area tech culture rather than mere internet noise.
Zero-Sum View Of Performance Compounds
- Jayden argues most performance drugs and peptides are zero-sum: benefits come with side effects.
- He emphasizes skepticism for otherwise healthy people using these compounds for cosmetic gains.
Assess Risk Before Trying Peptides
- Assess individual risk profiles before taking peptides; there is no one-size-fits-all rule.
- Read the data and weigh risk tolerance against potential upside for your health status.